Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06623422
What this trial is testing

Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 680
Large-scale testing (Phase 3)Active Not RecruitingNCT05239741
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)Ended earlyNCT03922711
What this trial is testing

Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Prilenia 23
Large-scale testing (Phase 3)Study completedNCT04776148
What this trial is testing

Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 563
Testing effectiveness (Phase 2)Ended earlyNCT01264861
What this trial is testing

Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging

Who this might be right for
Parkinson Disease
Newron Pharmaceuticals SPA 5
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Large-scale testing (Phase 3)Study completedNCT04676412
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 107
Early research (Phase 1)Study completedNCT05635461
What this trial is testing

Relative Bioavailability and Food Effect Study of CVN424

Who this might be right for
Parkinson's Disease
Cerevance Beta, Inc. 32
Not applicableUnknownNCT05713721
What this trial is testing

Sensorimotor Integration in Monogenic Parkinson-dystonia Syndromes

Who this might be right for
ParkinsonDystoniaDYT3+3 more
University Hospital Schleswig-Holstein 120
Not applicableStudy completedNCT02800460
What this trial is testing

New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients

Who this might be right for
Parkinson Disease
Institut National de la Santé Et de la Recherche Médicale, France 105
Large-scale testing (Phase 3)Active Not RecruitingNCT05152147
What this trial is testing

Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Who this might be right for
Gastric NeoplasmsGastroesophageal AdenocarcinomaEsophageal Adenocarcinoma
Jazz Pharmaceuticals 920
Large-scale testing (Phase 3)Ended earlyNCT04738487
What this trial is testing

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

Who this might be right for
Lung NeoplasmsNon-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC 1,264
Testing effectiveness (Phase 2)Ended earlyNCT00809302
What this trial is testing

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

Who this might be right for
Early Parkinson Disease
Neurogen Corporation 9
Testing effectiveness (Phase 2)Study completedNCT01568034
What this trial is testing

Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 10
Large-scale testing (Phase 3)Study completedNCT04191096
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Merck Sharp & Dohme LLC 1,251
Not applicableActive Not RecruitingNCT04284436
What this trial is testing

Study in Parkinson Disease of Exercise

Who this might be right for
Parkinson Disease
Northwestern University 370
Not applicableUnknownNCT03998787
What this trial is testing

Metabotropic Receptors For Glutamate Type 3 In Parkinson's

Who this might be right for
NeuroscienceMovement Disorders
Neuromed IRCCS 40
Early research (Phase 1)Study completedNCT02763852
What this trial is testing

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 18
Large-scale testing (Phase 3)Study completedNCT01227265
What this trial is testing

Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson DiseaseIdiopathic Parkinson's Disease
Merck Sharp & Dohme LLC 476
Next Page